Scientific letter
Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab
Diabetes mellitus asociada al tratamiento con inhibidores de puntos de control inmune: un caso clínico con atezolizumab
Pablo Rodríguez de Vera Gómez
, María del Castillo Tous Romero, Cristóbal Morales Portillo, Isabel Serrano Olmedo, María Asunción Martínez Brocca
Corresponding author
Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Virgen Macarena, Sevilla, Spain
Read
2066
Timeswas read the article
438
Total PDF
1628
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 22 | 7 | 29 |
| 2025 11 | 149 | 54 | 203 |
| 2025 10 | 92 | 23 | 115 |
| 2025 9 | 69 | 17 | 86 |
| 2025 8 | 80 | 19 | 99 |
| 2025 7 | 105 | 18 | 123 |
| 2025 6 | 61 | 4 | 65 |
| 2025 5 | 77 | 11 | 88 |
| 2025 4 | 36 | 3 | 39 |
| 2025 3 | 43 | 14 | 57 |
| 2025 2 | 36 | 6 | 42 |
| 2025 1 | 68 | 5 | 73 |
| 2024 12 | 39 | 3 | 42 |
| 2024 11 | 44 | 6 | 50 |
| 2024 10 | 18 | 12 | 30 |
| 2024 9 | 55 | 23 | 78 |
| 2024 8 | 32 | 20 | 52 |
| 2024 7 | 13 | 14 | 27 |
| 2024 6 | 19 | 8 | 27 |
| 2024 5 | 13 | 2 | 15 |
| 2024 4 | 18 | 11 | 29 |
| 2024 3 | 12 | 8 | 20 |
| 2024 2 | 5 | 4 | 9 |
| 2024 1 | 7 | 3 | 10 |
| 2023 12 | 18 | 6 | 24 |
| 2023 11 | 7 | 5 | 12 |
| 2023 10 | 19 | 4 | 23 |
| 2023 9 | 7 | 4 | 11 |
| 2023 8 | 14 | 1 | 15 |
| 2023 7 | 5 | 2 | 7 |
| 2023 6 | 15 | 0 | 15 |
| 2023 5 | 32 | 3 | 35 |
| 2023 4 | 26 | 4 | 30 |
| 2023 3 | 22 | 1 | 23 |
| 2023 2 | 19 | 2 | 21 |
| 2023 1 | 6 | 7 | 13 |
| 2022 12 | 9 | 3 | 12 |
| 2022 11 | 28 | 9 | 37 |
| 2022 10 | 52 | 6 | 58 |
| 2022 9 | 39 | 9 | 48 |
| 2022 8 | 19 | 11 | 30 |
| 2022 7 | 9 | 7 | 16 |
| 2022 6 | 17 | 7 | 24 |
| 2022 5 | 4 | 7 | 11 |
| 2022 4 | 16 | 5 | 21 |
| 2022 3 | 20 | 5 | 25 |
| 2022 2 | 25 | 6 | 31 |
| 2022 1 | 15 | 7 | 22 |
| 2021 12 | 28 | 11 | 39 |
| 2021 11 | 42 | 10 | 52 |
| 2021 10 | 2 | 1 | 3 |
Show all
